Genmab — Juli 2020
-
Det var mest dette studie jeg tænker på https://www.clinicaltrials.gov/ct2/show/NCT04487080?recrs=ab&cond=Lung+Cancer&sfpd_s=07%2F16%2F2020&sfpd_d=14&sel_rss=new14 som der blev linket til i går.
-
God morgen.
-
God morgen
-
British Journal of Haematology -
Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open‐label Phase II study https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16980 -
New Topline TEPEZZA
(teprotumumab-trbw) Data Underscore its Efficacy in Longer Disease Duration, Long-Term Durability and Potential for Retreatment in People Living with Thyroid Eye Disease (TED) https://apnews.com/792e5d2d37194348be8940fa297fcd30 -
En særmeddelelse: https://www.proinvestor.com/boards/85475
-
Tillykke Helge!!:-)
-
-
Seattle Genetics, Inc. (SGEN) CEO Clay Siegall on Q2 2020 Results - Earnings Call Transcript - on TV - https://seekingalpha.com/article/4362785-seattle-genetics-inc-sgen-ceo-clay-siegall-on-q2-2020-results-earnings-call-transcript?part=single
-
-
AbbVie- why the CD3xCD20 would be best in class - efficacy data reported puts it at higher end, safety profile has been very favourable , SC formulation, dosing schedule fits very well in the diseases we are looking at- that makes it a very strong profile
)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind